Biotech Values

[pcrutch]

Momenta Pharmaceuticals Obtains Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.

CAMBRIDGE, Mass., Oct. 7, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the United States District Court for the District of Massachusetts today entered an order enjoining Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. from offering to sell or selling their generic enoxaparin pending a hearing on October 20, 2011 on Momenta's motion for a preliminary injunction.

http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=612961